@article{1a586d63b0304bc98b73e9ca66cb721b,
title = "Functional interactors of three genome-wide association study genes are differentially expressed in severe chronic obstructive pulmonary disease lung tissue",
abstract = "In comparison to genome-wide association studies (GWAS), there has been poor replication of gene expression studies in chronic obstructive pulmonary disease (COPD). We performed microarray gene expression profiling on a large sample of resected lung tissues from subjects with severe COPD. Comparing 111 COPD cases and 40 control smokers, 204 genes were differentially expressed; none were at significant GWAS loci. The top differentially expressed gene was HMGB1, which interacts with AGER, a known COPD GWAS gene. Differentially expressed genes showed enrichment for putative interactors of the first three identified COPD GWAS genes IREB2, HHIP, and FAM13A, based on gene sets derived from protein and RNA binding studies, RNA-interference, a murine smoking model, and expression quantitative trait locus analyses. The gene module most highly associated for COPD in Weighted Gene Co-Expression Network Analysis (WGCNA) was enriched for B cell pathways, and shared seventeen genes with a mouse smoking model and twenty genes with previous emphysema studies. As in other common diseases, genes at COPD GWAS loci were not differentially expressed; however, using a combination of network methods, experimental studies and careful phenotype definition, we found differential expression of putative interactors of these genes, and we replicated previous human and mouse microarray results.",
author = "Morrow, {Jarrett D.} and Xiaobo Zhou and Taotao Lao and Zhiqiang Jiang and Demeo, {Dawn L.} and Cho, {Michael H.} and Weiliang Qiu and Suzanne Cloonan and Victor Pinto-Plata and Bartholome Celli and Nathaniel Marchetti and Criner, {Gerard J.} and Raphael Bueno and Washko, {George R.} and Kimberly Glass and John Quackenbush and Choi, {Augustine M.K.} and Silverman, {Edwin K.} and Hersh, {Craig P.}",
note = "Funding Information: We thank Drs. Amund Gulsvik, Per Bakke, Augusto Litonjua, Pantel Vokonas, Ruth Tal-Singer, and the GenKOLS, NETT/NAS, ECLIPSE, and COPDGene studies for use of their GWAS meta-analysis data.The COPDGene{\textregistered} study (R01 HL089856 and R01 HL089897). (NCT00608764) was funded by the National Institutes of Health and is also supported by the COPD Foundation through contributions made to an Industry Advisory Board comprised of AstraZeneca, Boehringer Ingelheim, Novartis, Pfizer, Siemens, GSK and Sunovion. The National Emphysema Treatment Trial was supported by the NHLBI N01HR76101, N01HR76102, N01HR76103, N01HR76104, N01HR76105, N01HR76106, N01HR76107, N01HR76108, N01HR76109, N01HR76110, N01HR76111, N01HR76112, N01HR76113, N01HR76114, N01HR76115, N01HR76116, N01HR76118 and N01HR76119, the Centers for Medicare and Medicaid Services and the Agency for Healthcare Research and Quality. The Normative Aging Study is supported by the Cooperative Studies Program/ERIC of the US Department of Veterans Affairs and is a component of the Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC). The Norway GenKOLS study (Genetics of Chronic Obstructive Lung Disease, GSK code RES11080), and the ECLIPSE study (NCT00292552; GSK code SCO104960) were funded by GlaxoSmithKline. This work was supported by National Institutes of Health [P01HL105339 to EKS, R01HL111759 to JQ, R01HL094635 to CPH, R01HL130512 to CPH, R01HL125583 to CPH, R01HL113264 to MHC, R01HL127200 to XZ].",
year = "2017",
month = mar,
day = "13",
doi = "10.1038/srep44232",
language = "English (US)",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
}